Top

Hematology and Cell Therapy

Published in:

01-06-1999 | Original articles

Ex vivo expansion CD34⁺/AC133⁺ - selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy

Authors: J. Vávrová, S. Filip, D. Vokurková, M. Bláha, J. Vanásek, L. Jebavy

Published in: Hematology and Cell Therapy | Issue 3/1999

Title: Ex vivo expansion CD34+/AC133+ - selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy
Authors: J. Vávrová
S. Filip
D. Vokurková
M. Bláha
J. Vanásek
L. Jebavy
Publication date: 01-06-1999
Publisher: Springer-Verlag
Published in: Hematology and Cell Therapy / Issue 3/1999
Print ISSN: 1269-3286
Electronic ISSN: 1279-8509
DOI: https://doi.org/10.1007/s00282-999-0105-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Keynote webinar | Spotlight on antibody–drug conjugates in cancer